A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia.

about

A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia.

Item

http://www.wikidata.org/entity/Q41872131

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

A model for prediction of FLT3 ...... nosed acute myeloid leukaemia.

@en

type

Item

label

A model for prediction of FLT3 ...... nosed acute myeloid leukaemia.

@en

prefLabel

A model for prediction of FLT3 ...... nosed acute myeloid leukaemia.

@en

P1476

A model for prediction of FLT3 ...... nosed acute myeloid leukaemia.

@en

P2093

Alan F List

http://www.w3.org/2001/XMLSchema#string

Cheryl L Willman

http://www.w3.org/2001/XMLSchema#string

Derek L Stirewalt

http://www.w3.org/2001/XMLSchema#string

Elihu H Estey

http://www.w3.org/2001/XMLSchema#string

Fabiana Ostronoff

http://www.w3.org/2001/XMLSchema#string

John E Godwin

http://www.w3.org/2001/XMLSchema#string

John M Pagel

http://www.w3.org/2001/XMLSchema#string

Pamela S Becker

http://www.w3.org/2001/XMLSchema#string

Paul C Hendrie

http://www.w3.org/2001/XMLSchema#string

Ravinder K Sandhu

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.

Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.

P304

130-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.12450

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

163

http://www.w3.org/2001/XMLSchema#string

P50

Frederick R. Appelbaum

Megan Othus

Stephen H Petersdorf

P577

2013-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

247154524

http://www.w3.org/2001/XMLSchema#string

P698

23829510

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

4128010

http://www.w3.org/2001/XMLSchema#string